We launch soon.

Sign up here and we'll send you a product overview and let you know when it's ready for download.

Our Company

Neurotrack is building the cognitive health platform of the future, giving people direct access to tools and technology to assess, strengthen, and monitor their cognitive health. The company was co-founded in 2012 by Elli Kaplan, and leading neuroscientists and researchers Stuart Zola, Ph.D., Elizabeth Buffalo, Ph.D., and Cecelia Manzanares.

Neurotrack Timeline

  • Jan 2020

    Sompo Partnership

    Neurotrack partners with Sompo Holdings to launch the Neurotrack Cognitive Health Program to policyholders in Japan.

  • Jun 2019

    Series C Funding

    Neurotrack raises $21M in Series C funding round.

  • Apr 2019

    Research Grant Awarded

    The National Institute of Aging, a division of the U.S. National Institutes of Health, awards Neurotrack with a $3.3M research grant.

  • Nov 2018

    Dai-ichi Life Partnership

    Neurotrack partners with Dai-ichi Life to launch its new dementia insurance product.

  • Mar 2018

    Series B Funding

    Neurotrack raises $13.7M in Series B funding round.

  • Jan 2016

    Series A Funding

    Neurotrack raises $7.5M in Series A funding round.

  • 2012

    Neurotrack is Founded

    Elli Kaplan co-founds Neurotrack with a mission to give people everywhere the tools to assess their risk for cognitive decline.

Meet Our Team

Executive Team

Elli Kaplan

Co-Founder and CEO

“What we’re building at Neurotrack matters - to families here and around the world, including mine.”

Nick Bott, Psy.D.

Chief Science Officer

“We are working on problems that are not only technically challenging, and biologically interesting but clinically meaningful and globally relevant.”

Mitch Underseth

Chief Financial Officer

Scott Andrews, Ph.D.

Vice President, Engineering

“I'm excited to be using the latest machine learning technology to build a cutting-edge platform that helps people facing cognitive decline.”

Jordan Glenn, Ph.D.

Vice President, Clinical Development

“Alzheimer's isn't about just treatment, but prevention. Neurotrack is working to help stop Alzheimer's Disease before it even begins.”

Davina Pallone

Vice President, Product

“Today's choices impact our future cognition. I'm inspired to design a program that empowers people to take control of their long-term cognitive health.”

Scientific Advisory Board

John Harrison, Ph.D.

Principal Consultant

Metis Cognition Ltd.

Richard Isaacson, MD

Director

Alzheimer's Prevention Clinic

Michael Ropacki

Vice President of Clinical Development and US Site Head

Oryzon Genomics

Mike Poole, M.D.

Venture Partner

Biomatics Capital

Dorene Rentz, Psy.D.

Co-Director

Center for Alzheimer Research and Treatment, Brigham and Women's Hospital

Scientific Co-Founders

Stuart Zola Ph.D.

Interim Provost Executive Vice President Academic Affairs

Professor, Psychiatry & Behavioral Sciences

Emory University School of Medicine

Elizabeth Buffalo Ph.D.

Professor, Department of Physiology & Biophysics

Professor, Department of Physiology & Biophysics University of Washington School of Medicine

Chief, Neuroscience Division

Washington National Primate Research Center

Cecelia Manzanares

Program Manager

Yerkes National Primate Research Center Emory University